Esperion Therapeutics
ESPR
#7606
Rank
NZ$0.52 B
Marketcap
$2.54
Share price
-4.00%
Change (1 day)
-45.54%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.25 Billion

According to Esperion Therapeutics's latest financial reports the company has NZ$0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.25 B97.36%
2023-12-31NZ$0.13 B-50.51%
2022-12-31NZ$0.26 B-30.78%
2021-12-31NZ$0.37 B-10.17%
2020-12-31NZ$0.42 B41.77%
2019-12-31NZ$0.29 B47.02%
2018-12-31NZ$0.20 B-28.06%
2017-12-31NZ$0.28 B-7.71%
2016-12-31NZ$0.30 B-1.51%
2015-12-31NZ$0.31 B129.58%
2014-12-31NZ$0.13 B84.82%
2013-12-31NZ$73.08 M823.38%
2012-12-31NZ$7.91 M293.21%
2011-12-31NZ$2.01 M
2002-12-31NZ$85.7 M-49.37%
2001-12-31NZ$0.16 B6.81%
2000-12-31NZ$0.15 B1302.75%
1999-12-31NZ$11.29 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.07 B 321.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.00 B 685.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$36.08 B 14,045.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.88 B 6,125.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.44 B 72.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.41 B 64.38%๐Ÿ‡บ๐Ÿ‡ธ USA